Over the two-day tour across Northern Minnesota, Klobuchar’s staff will hold meetings with first responders, elected officials, and advocates to discuss resources local leaders need to effectively fight the opioid epidemic; According to the Minnesota Department of Health, drug overdoses claimed the lives of at least 637 people in Minnesota in 2016
Last month, Klobuchar announced that Minnesota was awarded major federal funding aimed at combating the opioid epidemic and made available through bipartisan legislation that she led and supported; St. Louis County will receive a $675,000 grant while $6 million will go to the Minnesota Department of Human Services to expand access to medication-assisted treatment in Minnesota
MINNEAPOLIS – On Monday, October 16 and Tuesday, October 17, representatives with the office of U.S. Senator Amy Klobuchar will meet with first responders, advocates, and elected officials for a series of public forums in Northern Minnesota. During the discussions Klobuchar’s staff will provide updates on the Senator’s work to support local efforts to combat the opioid epidemic and hear firsthand from Northland leaders about resources needed to continue effectively responding at the local level. According to the Minnesota Department of Health, drug overdoses claimed the lives of at least 637 Minnesotans in 2016. Roughly 60 percent of the fatalities were related to opioid use. On Monday, October 16, Klobuchar’s staff will host forums in Mora, Brainerd, and Aitkin. On Tuesday, October 17, Klobuchar’s staff will host forums in Virginia and Duluth. The forums are free and open to the public.
Last month, Klobuchar announced that Minnesota was awarded major federal funding aimed at combating the opioid epidemic and made available through bipartisan legislation that she led and supported. St. Louis County will receive a $675,000 grant, which was appropriated by the Klobuchar-backed 21st Century CURES Act. The Minnesota Department of Human services will be awarded $6 million – some of which was made available through Klobuchar’sComprehensive Addiction and Recovery Act (CARA) – to expand access to medication-assisted treatment in Minnesota
Monday, October 16 at 9:00 a.m.
Lakes and Pines Community Action Center
1700 East Maple Avenue, Mora, MN 55051
Klobuchar was one of four senators, along with Senators Sheldon Whitehouse (D-RI), Rob Portman (R-OH), and Kelly Ayotte (R-NH), to lead theComprehensive Addiction and Recovery Act (CARA). This bipartisan bill, which was signed into law in July 2016, encourages states and local communities to pursue a full array of proven strategies in the fight against opioid addiction. At the end of 2016, $1 billion was made available by Congress to fund the national effort. To build on the monumental first step of CARA, Klobuchar introduced the Prescription Drug Monitoring Act, which would require the use of prescription drug monitoring programs (PDMPs) in all states that receive certain federal funding to combat opioid abuse and also requires states to make their PDMP data available to other states.
Earlier this year, she and ten other senators introduced the Budgeting for Opioid Addiction Treatment (LifeBOAT) Act, which would establish a reliable funding stream to provide and expand access to substance abuse treatment. She and a bipartisan group of senators also introduced the Synthetic Abuse and Labeling of Toxic Substances (SALTS) Act and the Synthetics Trafficking & Overdose Prevention (STOP) Act. The SALTS Act would make it easier to prosecute the sale of “analogue” drugs, which are synthetic substances that are substantially similar to illegal drugs. The STOP Act would help close a loophole in the U.S. postal system to stop dangerous synthetic drugs like fentanyl and carfentanil from being shipped through our borders to drug traffickers in the U.S.
In September 2014, the DEA implemented Klobuchar’s bipartisan Secure and Responsible Drug Disposal Act. Under the legislation, consumers are provided with more safe and responsible ways to dispose of unused prescription medications and controlled substances.
Posted in News.